CBS 2019
CBSMD教育中心
中 文

急性冠脉综合征

Abstract

Recommended Article

Complete Versus Culprit-Only Revascularization in STEMI: a Contemporary Review Door to Balloon Time: Is There a Point That Is Too Short? Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial Prognostic impact of atrial fibrillation in cardiogenic shock complicating acute myocardial infarction: a substudy of the IABP-SHOCK II trial Prognostic impact of non-culprit chronic total occlusions in infarct-related cardiogenic shock: results of the randomised IABP-SHOCK II trial The Wait for High-Sensitivity Troponin Is Over—Proceed Cautiously A case of influenza type a myocarditis that presents with ST elevation MI, cardiogenic shock, acute renal failure, and rhabdomyolysis and with rapid recovery after treatment with oseltamivir and intra-aortic balloon pump support

Review Article2017;376:2053-64.

JOURNAL:N Engl J Med. Article Link

Acute Myocardial Infarction

Jeffrey L. Anderson, David A. Morrow Keywords: Acute Myocardial Infarction; Definition; Epidemiologic Features; Diagnositc Triage; Risk Stratification; Initial Medical Care

ABSTRACT

Acute myocardial infarction with or without ST-segment elevation (STEMI or non-STEMI) is a common cardiac emergency, with the potential for substantial morbidity and mortality. The management of acute myocardial infarction has improved dramatically over the past three decades and continues to evolve. This review focuses on the initial presentation and in-hospital management of type 1 acute myocardial infarction.